<PAGE>

                          SECURITIES AND EXCHANGE COMMISSION
                                 WASHINGTON, DC 20549

                                     FORM 10-Q/A

(Mark One)
[X]  Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange
Act of 1934
For the quarterly period ended June 30, 1996 or

[  ]  Transition report pursuant to section 13 or 15(d) of the Securities
Exchange Act of 1934
For the Transition period from __________ to__________


                          Commission File Number :  0-19758

                                 Access Health, Inc.
                (Exact name of registrant as specified in its charter)

              Delaware                                68-0163589
    (State or other jurisdiction of      (I.R.S. Employer Identification No.)
     incorporation or organization)    

    11020 White Rock Road, Rancho Cordova, California     95670
        (Address of principal executive offices)       (Zip code)

                                    (916) 851-4000
                 (Registrant's telephone number, including area code)

                            Access Health Marketing, Inc.
                                    (Former name)


    Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

    Yes___X___          No______  

      Number of shares of Common Stock Outstanding at July 31, 1996: 12,576,674
                                       shares*


*  The number of shares is on a post-split basis.  On January 26, 1996, the
Registrant declared a 3-for-2 stock split which was effected as a stock dividend
for all stockholders of record on February 15, 1996.

<PAGE>
ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

    a)   Exhibits:
         
         10.1*     Amended and Restated Agreement of Limited Partnership of 
                   AHN Partners, L.P.
         10.2*     Admission Agreement dated April 15, 1996
         10.3*     Partnership Interest Option Agreement dated April 15, 1996
         10.4      Line of Credit Note dated May 7, 1996.

         * Confidential Treatment Requested



    b)   There have been no reports on Form 8-K filed during the quarter
         ended June 30, 1996.


                                          2

<PAGE>
                                      Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.




                                   ACCESS HEALTH, INC.





Date:   January 10, 1997          /S/   John V. Crisan
                                  -----------------------------------------
                                  John V. Crisan
                                  Senior Vice President and Chief 
                                    Financial Officer (principal financial 
                                    officer of Registrant)


                                          3